We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PDL CARVE-OUT INITIATIVES HURT GENERIC INTERESTS, DOWNEY SAYS
Big pharma has successfully persuaded 24 states to amend Medicaid laws to exempt expensive therapeutic drug classes from substitution rules requiring doctors to prescribe lower-priced alternatives, according to a generic drug executive who says the situation hurts the generic industry and state coffers.